AICPI
WHWK

ABG Innovation Capital Partners III’s Whitehawk Therapeutics WHWK Stock Holding History

ABG Innovation Capital Partners III’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,666
Closed -$64.5K – 1
2025
Q4 		$64.5K Hold
26,666
– – 100% 1
2025
Q3 		$50.7K Hold
26,666
– – 100% 1
2025
Q2 		$49.9K Hold
26,666
– – 100% 1
2025
Q1 		$47.5K Hold
26,666
– – 5.93% 2
2024
Q4 		$84.1K Hold
26,666
– – 7.77% 2
2024
Q3 		$54.9K Hold
26,666
– – 4.89% 2
2024
Q2 		$38.9K Hold
26,666
– – 4.53% 2
2024
Q1 		$62.4K Hold
26,666
– – 7.5% 2
2023
Q4 		$53.9K Hold
26,666
– – 5.99% 2
2023
Q3 		$129K Hold
26,666
– – 17.55% 2
2023
Q2 		$182K Hold
26,666
– – 24.91% 2
2023
Q1 		$193K Hold
26,666
– – 17.76% 2
2022
Q4 		$342K Hold
26,666
– – 26.12% 2
2022
Q3 		$377K Hold
26,666
– – 25.56% 2
2022
Q2 		$329K Hold
26,666
– – 24.48% 2
2022
Q1 		$453K Hold
26,666
– – 30.96% 3
2021
Q4 		$644K Hold
26,666
– – 37.25% 1
2021
Q3 		$783K Sell
26,666
-1
-0% -$30 32.53% 1
2021
Q2 		$676K Hold
26,667
– – 2.26% 4
2021
Q1 		$516K Hold
26,667
– – 0.25% 5
2020
Q4 		$392K Buy
+26,667
New +$570K 0.23% 5

Other funds holding WHWK

QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

ABG Innovation Capital Partners III's WHWK Position: Q1 2026 in Review

ABG Innovation Capital Partners III sold out of Whitehawk Therapeutics (WHWK) in Q1 2026, closing a stake of 26,666 shares — an estimated $64.5K sold.

ABG Innovation Capital Partners III first reported a position in WHWK in Q4 2020 and held it in 21 quarters. The position peaked at $783K in Q3 2021. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • ABG Innovation Capital Partners III reported no remaining Whitehawk Therapeutics position as of Q1 2026 after selling out during the quarter.
  • ABG Innovation Capital Partners III sold 26,666 Whitehawk Therapeutics shares in Q1 2026, an estimated $64.5K.
  • ABG Innovation Capital Partners III first reported a position in Whitehawk Therapeutics in Q4 2020 and held it in 21 quarters.
  • ABG Innovation Capital Partners III's Whitehawk Therapeutics position peaked at $783K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on ABG Innovation Capital Partners III's 13F filing for Q1 2026.